Cargando…
Using PDX for Preclinical Cancer Drug Discovery: The Evolving Field
The ability to create patient derived xenografts (PDXs) has evolved considerably from the breakthrough of the development of immune compromised mice. How researchers in drug discovery have utilized PDX of certain cancer types has also changed from traditionally selecting a few models to profile a dr...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5867567/ https://www.ncbi.nlm.nih.gov/pubmed/29498669 http://dx.doi.org/10.3390/jcm7030041 |